LAWSUITS NEWS & LEGAL INFORMATION
Nexium Side Effects Legal News Articles & Interviews
December 1, 2017. By Anne Wallace.
Washington, DC: The long-term use of drugs classed as proton pump inhibitors or PPIs , and marketed variously as Prevacid, Prilosec or Nexium, is dangerous for many reasons. Kidney damage, the focus of recently consolidated multidistrict litigation, is not the only problem. Long-term PPI use has also been associated with bone fractures and dementia in women, as well as the risk of birth defects. The issue for the lawsuits to come will be whether drug makers gave patients adequate warning of the dangers associated with their products and thus the opportunity to make informed choices.Read [ Are PPIs Especially Dangerous for Women? ]
June 10, 2017. By Deb Hipp.
Washington, DC:Plaintiffs who have filed lawsuits alleging that proton pump inhibitor (PPI) medications such as Nexium, Prilosec and Prevacid caused their kidney injuries have filed a motion to consolidate 172 pending federal lawsuits to a multidistrict litigation under one New Jersey judge.Read [ Proton Pump Inhibitor Lawsuit Plaintiffs Try Again For Multidistrict Litigation ]
March 12, 2017. By Brenda Craig.
Washington, DC The Washington DC based watchdog group, Public Citizen, was among the first to start ringing the warning bell. In 2011 Public Citizen demanded that the FDA warn patients and doctors that the use of the popular prescription acid-reducing drugs came with serious health risks.Read [ The Watchdog Group that Rang the Bell on Anti-acid Meds ]
August 23, 2016. By Brenda Craig.
Dallas, TX As many as 15 million people in the US are regular users of popular antacid medications. Sold both over the counter and by prescription the medications are heavily marketed direct to consumers under brand names like Nexium, Prevacid, Prilosec, Protonix, AciPhex and Zegrid.Read [ Block Buster Antacid Meds Target of Lawsuits ]
August 22, 2016. By Heidi Turner.
Portland, OR: They're the pills millions of people use to treat symptoms of acid reflux, but in addition to being linked to serious side effects, proton pump inhibitors may also be linked to health problems when people discontinue the medications. Studies suggest proton pump inhibitors (known also as PPIs), are linked to an increased risk of bone fractures, heart attacks, and kidney disease. Concerns have also been raised, however, that when patients discontinue their use of PPIs, they suffer more serious heartburn symptoms.Read [ Stomaching the Side Effects of Proton Pump Inhibitors ]
March 16, 2014. By Heidi Turner.
Read [ Nexium Plaintiffs Oppose Lawsuit Dismissal ]
Los Angeles, CA: Plaintiffs involved in Nexium lawsuits have opposed AstraZeneca's motion to dismiss the lawsuits. In all, up to 58 lawsuits are involved, with plaintiffs alleging they were not given the opportunity to fix reported issues with the lawsuits, including not having paperwork submitted in time. According to National Law Journal (3/13/14), more than 730 plaintiffs have reportedly not filed necessary paperwork.
April 12, 2013. By Heidi Turner.
Read [ Proving Nexium Side Effects Caused Fractures ]
Boston, MA Patients who began taking Nexium before an updated warning was issued about the risk of Nexium side effects may be eligible to file a lawsuit if they suffered a fracture or bone degradation, but they must speak to an attorney soon. That is because the statute of limitations began running when the updated warning was announced. Furthermore, they must be able to show that because of the length of time they took the drug and the dose they took it at, it is likely the Nexium caused their fracture and not something else, says Ben Stewart, of Stewart Law Group PLLC.
February 13, 2013. By Gordon Gibb.
Read [ The Pressure’s On AstraZeneca and Nexium ]
Boston, MA The manufacturer of a popular acid reflux drug, Nexium, appears to be in a state of flux with various issues percolating inherent with the pharmaceutical company. AstraZeneca, with a new leader at the helm, has reportedly axed thousands of jobs and is facing diminished returns from Nexium sales when the patent on the prescription version of the drug expires in the US next year.